InMed Pharmaceuticals Inc (INM)
NASDAQ
Quarter End | 12 2022 | 3 2023 | 6 2023 | 9 2023 | 12 2023 | 3 2024 | 6 2024 | 9 2024 |
---|---|---|---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総資産 | 16.92M | 14.73M | 14.11M | 10.92M | 15.26M | 13.36M | 11.82M | 10.47M |
流動資産合計 | 14.02M | 11.84M | 11.33M | 8.3M | 11.81M | 10.06M | 8.69M | 7.28M |
現金および同等物 | 11.45M | 9.6M | 8.91M | 6.74M | 9.54M | 7.6M | 6.57M | 5.58M |
非流動資産合計 | 3.61M | 3.64M | 3.5M | 3.24M | 1.78M | 4.67M | 4.38M | 4.53M |
負債合計 | 2.59M | 2.34M | 2.02M | 1.34M | 2.48M | 2.25M | 2.62M | 2.07M |
流動負債合計 | 2.4M | 2.27M | 2M | 1.34M | 1.68M | 1.53M | 1.97M | 1.44M |
非流動負債合計 | 368k | 74k | 34k | 0 | 1.61M | 1.45M | 1.29M | 1.27M |
普通株 | 74.86M | 113.32M | 77.62M | 77.62M | 79.94M | 80.61M | 82.78M | 84.2M |
留保所得 | -99.06M | -101.06M | -101.4M | 129k | -105.42M | -107.14M | -109.08M | 128k |
年末 2024年6月30日 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総資産 | 8.34M | 28.06M | 19.79M | 7.8M | 9.78M | 12.79M | 14.11M | 11.82M |
流動資産合計 | 6.94M | 26.73M | 18.55M | 6.31M | 8.38M | 9.6M | 11.33M | 8.69M |
現金および同等物 | 6.71M | 24.13M | 12.87M | 5.81M | 7.36M | 6.18M | 8.91M | 6.57M |
非流動資産合計 | 7.97M | 27.13M | 18.23M | 5.88M | 7.38M | 9.08M | 12.09M | 9.21M |
負債合計 | 370k | 938k | 1.56M | 1.93M | 2.41M | 3.71M | 2.02M | 2.62M |
流動負債合計 | 370k | 938k | 1.56M | 1.68M | 2.22M | 3.32M | 2M | 1.97M |
非流動負債合計 | 0 | 0 | 0 | 498k | 380k | 778k | 34k | 1.29M |
総資本 | 7.97M | 27.13M | 18.23M | 5.88M | 7.38M | 9.08M | 12.09M | 9.21M |
普通株 | 43.15M | 68.06M | 68.58M | 53.07M | 60.59M | 70.72M | 77.62M | 82.78M |
留保所得 | -42.8M | -51.32M | -64.57M | -64.65M | -74.85M | -93.45M | -101.4M | -109.08M |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約